Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Madrigal Pharmaceuticals EBITDA 2011-2025 | MDGL

Madrigal Pharmaceuticals annual and quarterly EBITDA history from 2011 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Madrigal Pharmaceuticals EBITDA for the quarter ending September 30, 2025 was $-0.112B, a 3.66% decline year-over-year.
  • Madrigal Pharmaceuticals EBITDA for the twelve months ending September 30, 2025 was $-0.303B, a 44.49% decline year-over-year.
  • Madrigal Pharmaceuticals 2024 annual EBITDA was $-0.495B, a 31.13% increase from 2023.
  • Madrigal Pharmaceuticals 2023 annual EBITDA was $-0.378B, a 29.16% increase from 2022.
  • Madrigal Pharmaceuticals 2022 annual EBITDA was $-0.292B, a 20.75% increase from 2021.
Madrigal Pharmaceuticals Annual EBITDA
(Millions of US $)
2024 $-495
2023 $-378
2022 $-292
2021 $-242
2020 $-206
2019 $-95
2018 $-41
2017 $-32
2016 $-25
2015 $-3
2014 $-83
2013 $-87
2012 $-60
2011 $-44
2010 $-35
Madrigal Pharmaceuticals Quarterly EBITDA
(Millions of US $)
2025-09-30 $-112
2025-06-30 $-46
2025-03-31 $-78
2024-12-31 $-66
2024-09-30 $-116
2024-06-30 $-162
2024-03-31 $-151
2023-12-31 $-116
2023-09-30 $-98
2023-06-30 $-86
2023-03-31 $-78
2022-12-31 $-85
2022-09-30 $-80
2022-06-30 $-70
2022-03-31 $-57
2021-12-31 $-64
2021-09-30 $-63
2021-06-30 $-62
2021-03-31 $-53
2020-12-31 $-59
2020-09-30 $-59
2020-06-30 $-50
2020-03-31 $-38
2019-12-31 $-30
2019-09-30 $-24
2019-06-30 $-23
2019-03-31 $-18
2018-12-31 $-14
2018-09-30 $-11
2018-06-30 $-8
2018-03-31 $-7
2017-12-31 $-9
2017-09-30 $-9
2017-06-30 $-8
2017-03-31 $-6
2016-12-31 $-8
2016-09-30 $-14
2016-06-30 $-3
2016-03-31 $-1
2015-12-31 $37
2015-09-30 $-1
2015-06-30 $-19
2015-03-31 $-20
2014-12-31 $-20
2014-09-30 $-19
2014-06-30 $-22
2014-03-31 $-23
2013-12-31 $-23
2013-09-30 $-22
2013-06-30 $-22
2013-03-31 $-20
2012-12-31 $-18
2012-09-30 $-14
2012-06-30 $-14
2012-03-31 $-14
2011-12-31 $-10
2011-09-30 $-12
2011-06-30 $-12
2011-03-31 $-11
2010-12-31 $-8
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.096B $0.180B
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $74.015B 28.11
Zoetis (ZTS) United States $52.689B 18.86
Takeda Pharmaceutical (TAK) Japan $43.402B 8.86
Daiichi Sankyo, - (DSNKY) Japan $41.941B 20.89
BeOne Medicines - (ONC) Switzerland $36.448B 193.23
Sandoz Group AG (SDZNY) Switzerland $29.586B 0.00
United Therapeutics (UTHR) United States $19.548B 17.20
Merck (MKKGY) Germany $16.433B 10.69
Neurocrine Biosciences (NBIX) United States $15.434B 37.03
Shionogi (SGIOY) Japan $14.445B 13.27
Summit Therapeutics (SMMT) United States $14.228B 0.00
Ionis Pharmaceuticals (IONS) United States $12.002B 0.00
IPSEN (IPSEY) France $11.841B 0.00
Orion OYJ (ORINY) Finland $8.793B 25.12
Eisai (ESAIY) $8.166B 0.00
Corcept Therapeutics (CORT) United States $7.685B 83.02
Stevanato Group S.p.A (STVN) Italy $7.392B 41.37
Grifols, S.A (GRFS) Spain $5.748B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.549B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.173B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.096B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.662B 17.40
Centessa Pharmaceuticals (CNTA) United Kingdom $3.058B 0.00
Hypermarcas (HYPMY) Brazil $2.899B 21.80
Dyne Therapeutics (DYN) United States $2.600B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.580B 8.23
Soleno Therapeutics (SLNO) United States $2.339B 0.00
Ocular Therapeutix (OCUL) United States $2.265B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.839B 21.80
Avadel Pharmaceuticals (AVDL) Ireland $1.817B 0.00
Guardian Pharmacy Services (GRDN) United States $1.804B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.373B 0.00
Collegium Pharmaceutical (COLL) United States $1.281B 6.36
Harrow (HROW) United States $1.274B 0.00
Xeris Biopharma Holdings (XERS) United States $1.245B 0.00
Oruka Therapeutics (ORKA) United States $1.175B 0.00
Evotec AG (EVO) Germany $1.174B 0.00
Relay Therapeutics (RLAY) United States $1.126B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.111B 0.00
Enliven Therapeutics (ELVN) United States $1.084B 0.00
Nektar Therapeutics (NKTR) United States $1.048B 0.00
Xencor (XNCR) United States $1.000B 0.00
Cronos Group (CRON) Canada $0.946B 0.00
ProKidney (PROK) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.810B 0.00
Theravance Biopharma (TBPH) United States $0.749B 61.96
Aquestive Therapeutics (AQST) United States $0.748B 0.00
Savara (SVRA) United States $0.688B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.656B 5.85
Elite Pharmaceuticals (ELTP) United States $0.645B 0.00
Bioventus (BVS) United States $0.618B 12.68
Siga Technologies (SIGA) United States $0.585B 8.01
KalVista Pharmaceuticals (KALV) United States $0.550B 0.00
Akebia Therapeutics (AKBA) United States $0.533B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
4D Molecular Therapeutics (FDMT) United States $0.510B 0.00
Esperion Therapeutics (ESPR) United States $0.504B 0.00
Organogenesis (ORGO) United States $0.493B 0.00
Lexeo Therapeutics (LXEO) United States $0.455B 0.00
Galectin Therapeutics (GALT) United States $0.360B 0.00
USANA Health Sciences (USNA) United States $0.350B 9.78
Altimmune (ALT) United States $0.348B 0.00
Lyell Immunopharma (LYEL) United States $0.344B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.333B 51.25
Korro Bio (KRRO) United States $0.306B 0.00
Aldeyra Therapeutics (ALDX) United States $0.289B 0.00
Larimar Therapeutics (LRMR) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.252B 0.00
Aclaris Therapeutics (ACRS) United States $0.246B 0.00
Achieve Life Sciences (ACHV) Canada $0.242B 0.00
Nature's Sunshine Products (NATR) United States $0.242B 14.30
Journey Medical (DERM) United States $0.242B 0.00
AleAnna (ANNA) United States $0.219B 0.00
Avalo Therapeutics (AVTX) United States $0.203B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
MediWound (MDWD) Israel $0.200B 0.00
OmniAb (OABI) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.166B 0.00
Protara Therapeutics (TARA) United States $0.166B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.153B 0.00
Cassava Sciences (SAVA) United States $0.143B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.127B 0.00
Inhibikase Therapeutics (IKT) United States $0.111B 0.00
Surrozen (SRZN) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Context Therapeutics (CNTX) United States $0.098B 0.00
Champions Oncology (CSBR) United States $0.095B 34.40
Vivani Medical (VANI) United States $0.093B 0.00
Avita Medical (RCEL) United States $0.091B 0.00
VAXART, INC (VXRT) United States $0.087B 0.00
Relmada Therapeutics (RLMD) United States $0.087B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.079B 0.00
Prelude Therapeutics (PRLD) United States $0.076B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Nutriband (NTRB) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.063B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
Talphera (TLPH) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Plus Therapeutics (PSTV) United States $0.051B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.046B 0.00
Karyopharm Therapeutics (KPTI) United States $0.045B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Telomir Pharmaceuticals (TELO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 27.38
Iterum Therapeutics (ITRM) Ireland $0.028B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Vyome Holdings (HIND) United States $0.021B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Heatwurx (PCSA) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Lipocine (LPCN) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
NewcelX (NCEL) Switzerland $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.26
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00